Cargando…
Patent ductus arteriosus, systemic NT-proBNP concentrations and development of bronchopulmonary dysplasia in very preterm infants: retrospective data analysis from a randomized controlled trial
BACKGROUND: Patent ductus arteriosus (PDA) is a common complication in very preterm infants. It is known that there is an association between PDA and development of bronchopulmonary dysplasia (BPD) or death before the postmenstrual age (PMA) of 36 weeks, but this association remains one of the most...
Autores principales: | Potsiurko, Solomiia, Dobryanskyy, Dmytro, Sekretar, Lesya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214290/ https://www.ncbi.nlm.nih.gov/pubmed/34147090 http://dx.doi.org/10.1186/s12887-021-02750-9 |
Ejemplares similares
-
Predictive Value of Blood N-Terminal Pro-Brain Natriuretic Peptide Concentrations for Early Patent Ductus Closure in Very Preterm Infants
por: Potsiurko, Solomiia, et al.
Publicado: (2021) -
Exploring the NT-proBNP expression in Premature Infants with Patent Ductus Arteriosus (PDA) by Echocardiography
por: Shi, Yunlong, et al.
Publicado: (2021) -
NT-proBNP Levels Improve the Ability of Predicting a Hemodynamically Significant Patent Ductus Arteriosus in
Very Low-Birth-Weight Infants
por: Buddhe, Sujatha, et al.
Publicado: (2012) -
Patent ductus arteriosus, tracheal ventilation, and the risk of bronchopulmonary dysplasia
por: Clyman, Ronald I., et al.
Publicado: (2021) -
Patent ductus arteriosus and the risk of bronchopulmonary dysplasia-associated pulmonary hypertension
por: Nawaytou, Hythem, et al.
Publicado: (2023)